¿Porqué Anestesia Total Intravenosa en Cirugía Plástica?

CRITICAL CARE & EMERGENGY MEDICINE VOL. 4

¿Why Total Intravenous Anesthesia in Plastic Surgery?

Blanca O. Aquino Tamayo 1, Arturo Contreras Ríos 2, Aurelio R. Contreras Dorantes 3.

1 Centro de Alta Especialidad Dr. Rafael Lucio, Xalapa Veracruz. México.
2 Cirugía Plástica Estética y Reconstructiva Hospital Ángeles Xalapa, Veracruz. México.
3 Cirugía Plástica Estética y Reconstructiva Hospital Ángeles Xalapa, Veracruz. México.

Abstract

Plastic, aesthetic, and reconstructive surgery has become one of the most in-demand medical specialties worldwide, encompassing patients from diverse ages and socioeconomic backgrounds. These procedures require a broad anesthetic approach, ranging from pediatric cleft lip and palate repair to facial rejuvenation surgeries in older adults and body contouring in patients after massive weight loss. The anesthetic challenge lies not only in managing the surgical risk but also in optimizing perioperative outcomes across a highly heterogeneous patient population. 

Aesthetic and reconstructive procedures are inherently complementary; every reconstructive intervention carries aesthetic considerations, and aesthetic surgeries often involve elements of reconstruction.
Anesthesiologists play a key role in enhancing outcomes and patient satisfaction. This review aims to analyze the pharmacological characteristics of agents used in Total Intravenous Anesthesia, exploring how these drugs may positively influence recovery profiles and overall satisfaction in patients undergoing plastic surgery

La cirugía plástica, estética y reconstructiva se ha convertido en una de las especialidades médicas más demandadas a nivel mundial, abarcando a pacientes de todas las edades y todos los niveles socioeconómicos. Estos procedimientos requieren un enfoque anestésico amplio, que abarca desde la reparación de labio y paladar hendido en niños hasta cirugías de rejuvenecimiento facial en adultos mayores y remodelación corporal en pacientes tras una pérdida de peso significativa. El reto anestésico radica no solo en el manejo del riesgo quirúrgico, sino también en optimizar los resultados perioperatorios en una población de pacientes altamente heterogénea.
Los procedimientos estéticos y reconstructivos son inherentemente complementarios; toda intervención reconstructiva con lleva consideraciones estéticas, y las cirugías estéticas a menudo incluyen elementos de reconstrucción. Los anestesiólogos desempeñan un papel clave en la mejora de los resultados y la satisfacción del paciente. Esta revisión tiene como objetivo analizar las características farmacológicas de los agentes utilizados en la Anestesia Total Intravenosa, explorando cómo estos fármacos pueden influir positivamente en los perfiles de recuperación y la satisfacción general de los pacientes sometidos a cirugía plástica.
.

TIVA; anesthesia, dexmedetomidine, propofol, remifentanil, plastic surgery.

Blanca O. Aquino Tamayo.
Centro de Alta Especialidad Dr. Rafael Lucio, Xalapa Veracruz. México.

Arturo Contreras Ríos.
Cirugía Plástica Estética y Reconstructiva Hospital Ángeles Xalapa, Veracruz. México.

Aurelio R. Contreras Dorantes.
Cirugía Plástica Estética y Reconstructiva Hospital Ángeles Xalapa, Veracruz. México

  1. Scuderi N, Toth BA, editors. International Textbook of Aesthetic Surgery. 1st ed. Berlin: Springer; 2016.
  2. Aquino Tamayo BO. Anestesia total intravenosa para cirugía plástica. Anest Mex. 2020;32(2):30–9.
  3. International Society of Aesthetic Plastic Surgery (ISAPS). ISAPS International Survey on Aesthetic/Cosmetic Procedures Performed in 2023. Mount Royal, NJ: ISAPS; 2024. https://www.isaps.org/media/rxnfqibn/isaps-global-survey_2023.pdf
  4. Montrief T, Bornstein K, Ramzy M, Koyfman A, Long BJ. Plastic surgery complications: a review for emergency clinicians. West J Emerg Med. 2020;21(6):179–89. doi:10.5811/westjem.2020.6.46415.
  5. Rohrich RJ, Savetsky IL, Avashia YJ. Assessing cosmetic surgery safety: the evolving data. Plast Reconstr Surg Glob Open. 2020;8(5):e2643. doi:10.1097/GOX.0000000000002643.
  6. Schafer RE, Blazel MM, Nowacki AS, Schwarz GS. Risk of complications in combined plastic surgery procedures using the Tracking Operations and Outcomes for Plastic Surgeons database. Aesthet Surg J. 2023;43(11):1384–92. doi:10.1093/asj/sjad124.
  7. Mak QHY, Chan HT, Irwin MG. Anaesthesia for plastic and reconstructive surgery. Anaesth Intensive Care Med. 2021;22(1):64–9. doi:10.1016/j.mpaic.2020.11.006.
  8. Lee S. Dexmedetomidine: present and future directions. Korean J Anesthesiol. 2019;72(4):323–30. doi:10.4097/kja.19259
  9. Kotanoğlu MS, et al. The outcomes of dexmedetomidine and calcitriol on flap viability. Acta Cir Bras. 2020;35(9): e202000903. doi:10.1590/s0102-865020200090000003.
  10. Fang M, He J, Ma X, Li W, Lin D. Protective effects of dexmedetomidine on the survival of random flaps. Biomed Pharmacother. 2020;128:110261. doi:10.1016/j.biopha.2020.110261.
  11. Bidkar PU, Dey A, Chatterjee P, Ramadurai R, Joy JJ. Targetcontrolled infusion – past, present, and future. J Anaesthesiol Clin Pharmacol. 2024;40(3):371–80. doi:10.4103/joacp.joacp_64_23.
  12. Yi S, Cao H, Zheng W, Wang Y, Li P, Wang S, Zhou Z. Targeting the opioid remifentanil: protective effects and molecular mechanisms against organ ischemia-reperfusion injury. Biomed Pharmacother. 2023;167:115472. doi:10.1016/j.biopha.2023.115472
  13. Eleveld DJ, Proost JH, Vereecke H, Absalom AR, Olofsen E, Vuyk J, Struys MMRF. An allometric model of remifentanil pharmacokinetics and pharmacodynamics. Anesthesiology. 2017;126(6):1005–18. doi:10.1097/ALN.000000000000 1634.
  14. Irwin MG, Chung CKE, Ip KY, Wiles MD. Influence of propofolbased total intravenous anaesthesia on peri-operative outcome measures: a narrative review. Anaesthesia. 2020;75(Suppl1):e90–e100. doi:10.1111/anae.14905.
  15. Chalkias A, Xanthos T, Papalois A, Iacovidou N. Baseline values and kinetics of IL-6, procalcitonin, and TNF-α in Landrace-Large White swine anesthetized with propofol-based total intravenous anesthesia. Biomed Res Int. 2021;2021:6672573. doi:10.1155/2021/6672573.
  16. Sahinovic MM, Struys MMRF, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018;57(12):1539–58. doi:10.1007/s40262-018-0672-3.
  17. Gan TJ, Belani KG, Bergese S, Chung F, Diemunsch P, Habib AS, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2020; 131(2):411–48. doi:10.1213/ANE.0000000000004833
  18. Scharfetter S, Puchner J, Schwaiger K, Hitzl W, Buben P, Wechselberger G. Emesis as a risk factor for postoperative hematoma in abdominoplasty: a retrospective study in 189 cases. Plast Reconstr Surg Glob Open. 2024;12(7):e5969. doi:10.1097/GOX.0000000000005969
  19. Cao X, White PF, Ma H. An update on the management of postoperative nausea and vomiting. J Anesth. 2017;31(4):617–26. doi:10.1007/s00540-017-2363-x.
  20. Lee B, Shin HJ, Kweon KH, Kim NY. Effect of sevoflurane-remifentanil and propofol-remifentanil anesthesia on glycocalyx shedding during deep inferior epigastric perforator flap breast reconstruction: a prospective randomized, controlled trial. Anesth Pain Med. 2023;18:148–58. doi:10.17085/apm.22240.
  21. Kim HJ, Kim DK, Kim HY, Kim JK, Choi SW. Risk factors of emergence agitation in adults undergoing general anesthesia for nasal surgery. Clin Exp Otorhinolaryngol. 2015;8(1):46–51. doi:10.3342/ceo.2015.8.1.46.
  22. Talih G, Yüksek A, Şahin E. Evaluation of emergence agitation after general anaesthesia in rhinoplasty patients: inhalation anaesthesia versus total intravenous anaesthesia. Am J Otolaryngol. 2020;41(3):102387. doi:10.1016/j.amjoto.2020.102387.
  23. Fan X, Cai H, Pan B, Xie Y. Comparison of dexmedetomidine and remifentanil on reducing coughing during emergence from anesthesia with tracheal intubation: a meta-analysis. Front Pharmacol. 2022;13:993239. doi:10.3389/fphar.2022.993239.
  24. Purohit A, Kumar M, Kumar N, Bindra A, Pathak S, Yadav A. Comparison between dexmedetomidine and lidocaine for attenuation of cough response during tracheal extubation: a systematic review and meta-analysis. Indian J Anaesth. 2024; 68:415–25.
  25. Foster L, Foppiani J, Patel A, Brady K, Adams AJ, Choudry U, Lin SJ. The use of enhanced recovery after surgery (ERAS) protocols in plastic surgery: a systematic review and meta-analysis of the literature. J Plast Reconstr Aesthet Surg. 2025;103:273– 81. doi:10.1016/j.bjps.2025.01.072.
  26. Kampman JM, Hermanides J, Hollmann MW, Gilhuis CN, Bloem WAH, Schraag S, Pradelli L, Repping S, Sperna Weiland NH. Mortality and morbidity after total intravenous anaesthesia versus inhalational anaesthesia: a systematic review and metaanalysis. EClinicalMedicine. 2024;72:102636. doi:10.1016/j.eclinm.2024.102636.
[1] Blanca O. Aquino Tamayo, Arturo Contreras Ríos, and Aurelio R. Contreras Dorantes. 2025. ¿Porqué Anestesia Total Intravenosa en Cirugía Plástica? CRITICAL CARE & EMERGENGY MEDICINE. Vol. 4, pp. 28–34. DOI: www.doi.org/10.58281/ccem25073102.

Licencia

© 2025 Critical Care & Emergency Medicine by Ediciones Prado. This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) .

Licencia Creative Commons CC BY 4.0

The copyrights of the articles published in Critical Care & Emergency Medicine belong to Ediciones Prado. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Critical Care & Emergency Medicine without prior authorization for non-commercial use.

ISSN

2992-6785

eISSN: 2992-6785
DOI: 10.3989/ccem

Indexación

Patrocinadores

Scroll al inicio